| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 1.43e-09 | 6 | 64 | 4 | GO:0031800 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 1.70e-07 | 16 | 64 | 4 | GO:0035256 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 2.21e-07 | 17 | 64 | 4 | GO:0072542 | |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 3.13e-07 | 5 | 64 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 4.47e-07 | 20 | 64 | 4 | GO:0019211 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 8.08e-07 | 54 | 64 | 5 | GO:0005246 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 2.60e-06 | 9 | 64 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 3.71e-06 | 10 | 64 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 8.78e-06 | 13 | 64 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 1.11e-05 | 14 | 64 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.32e-05 | 162 | 64 | 6 | GO:0099106 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 1.71e-05 | 16 | 64 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 1.72e-05 | 100 | 64 | 5 | GO:0019888 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.86e-05 | 172 | 64 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.98e-05 | 174 | 64 | 6 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 2.18e-05 | 177 | 64 | 6 | GO:0141108 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 2.48e-05 | 18 | 64 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 3.10e-05 | 113 | 64 | 5 | GO:0019208 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | HDAC6 ANK2 CALM1 CALM2 FEZ1 LMO7 CALM3 ARPC5L KIFC3 PLEC RCAN3 MAPK8IP3 NLRP5 | 3.77e-05 | 1099 | 64 | 13 | GO:0008092 |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 4.63e-05 | 22 | 64 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | protein kinase binding | ANK2 CALM1 CALM2 FEZ1 CALM3 XIAP TNIP1 PRKCSH RAD54L2 RHOF MAPK8IP3 | 9.32e-05 | 873 | 64 | 11 | GO:0019901 |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN9 CABP1 CABP2 CABP5 CABP7 CALM1 CALM2 CALM3 CALML3 PRKCSH | 1.26e-04 | 749 | 64 | 10 | GO:0005509 |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.33e-04 | 81 | 64 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | kinase binding | ANK2 CALM1 CALM2 FEZ1 CALM3 XIAP TNIP1 PRKCSH RAD54L2 RHOF MAPK8IP3 | 2.33e-04 | 969 | 64 | 11 | GO:0019900 |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 2.77e-04 | 98 | 64 | 4 | GO:0048306 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 3.54e-04 | 43 | 64 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | U3 snoRNA binding | 5.46e-04 | 11 | 64 | 2 | GO:0034511 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 7.71e-04 | 13 | 64 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.50e-03 | 18 | 64 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | CABP1 PPP4R3B PIK3R6 CALM1 CALM2 CALM3 HRG XIAP XRCC5 RHOF CWF19L1 RCAN3 | 1.63e-03 | 1418 | 64 | 12 | GO:0030234 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 2.01e-03 | 78 | 64 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 4.49e-03 | 337 | 64 | 5 | GO:0001664 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 5.31e-03 | 34 | 64 | 2 | GO:0046625 | |
| GeneOntologyMolecularFunction | snoRNA binding | 5.31e-03 | 34 | 64 | 2 | GO:0030515 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.05e-08 | 9 | 64 | 4 | GO:0060316 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 2.85e-08 | 3 | 64 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 1.30e-07 | 39 | 64 | 5 | GO:1901021 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 2.50e-07 | 18 | 64 | 4 | GO:0010649 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 2.84e-07 | 5 | 64 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 5.66e-07 | 6 | 64 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 5.66e-07 | 6 | 64 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 5.91e-07 | 22 | 64 | 4 | GO:0010881 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 8.29e-07 | 56 | 64 | 5 | GO:2001259 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 1.20e-06 | 26 | 64 | 4 | GO:0060314 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 1.58e-06 | 8 | 64 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 1.63e-06 | 28 | 64 | 4 | GO:0010882 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 2.17e-06 | 30 | 64 | 4 | GO:0098901 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.22e-06 | 33 | 64 | 4 | GO:0010880 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 4.11e-06 | 35 | 64 | 4 | GO:0010644 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 4.62e-06 | 11 | 64 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 5.15e-06 | 37 | 64 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 5.24e-06 | 81 | 64 | 5 | GO:0098900 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 6.14e-06 | 12 | 64 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 6.14e-06 | 12 | 64 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 6.39e-06 | 39 | 64 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 7.97e-06 | 13 | 64 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 9.80e-06 | 92 | 64 | 5 | GO:1901019 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.04e-05 | 44 | 64 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 1.27e-05 | 97 | 64 | 5 | GO:0032414 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 1.33e-05 | 98 | 64 | 5 | GO:0051279 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 1.48e-05 | 48 | 64 | 4 | GO:0051281 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 1.55e-05 | 16 | 64 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 1.88e-05 | 17 | 64 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 2.04e-05 | 107 | 64 | 5 | GO:0032411 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 2.24e-05 | 109 | 64 | 5 | GO:1904427 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 2.66e-05 | 19 | 64 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 3.37e-05 | 59 | 64 | 4 | GO:0086065 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 3.64e-05 | 21 | 64 | 3 | GO:1901386 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 5.50e-05 | 24 | 64 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 6.92e-05 | 138 | 64 | 5 | GO:2001257 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 7.04e-05 | 26 | 64 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 8.24e-05 | 74 | 64 | 4 | GO:0010921 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 9.04e-05 | 146 | 64 | 5 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 9.34e-05 | 147 | 64 | 5 | GO:0051283 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 9.83e-05 | 29 | 64 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 9.95e-05 | 149 | 64 | 5 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.13e-04 | 153 | 64 | 5 | GO:0051208 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 1.16e-04 | 154 | 64 | 5 | GO:0051928 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 1.20e-04 | 31 | 64 | 3 | GO:0010922 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 1.33e-04 | 32 | 64 | 3 | GO:0010800 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 1.41e-04 | 6 | 64 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 1.42e-04 | 256 | 64 | 6 | GO:0006470 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.55e-04 | 87 | 64 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 1.69e-04 | 89 | 64 | 4 | GO:0055117 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 2.06e-04 | 174 | 64 | 5 | GO:1904064 | |
| GeneOntologyBiologicalProcess | regulation of voltage-gated calcium channel activity | 2.22e-04 | 38 | 64 | 3 | GO:1901385 | |
| GeneOntologyBiologicalProcess | autophagosome membrane docking | 2.62e-04 | 8 | 64 | 2 | GO:0016240 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 2.64e-04 | 100 | 64 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 2.79e-04 | 41 | 64 | 3 | GO:1901020 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 3.24e-04 | 192 | 64 | 5 | GO:0034767 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 3.32e-04 | 193 | 64 | 5 | GO:0071902 | |
| GeneOntologyBiologicalProcess | mitochondrion-endoplasmic reticulum membrane tethering | 3.36e-04 | 9 | 64 | 2 | GO:1990456 | |
| GeneOntologyBiologicalProcess | substantia nigra development | 3.68e-04 | 45 | 64 | 3 | GO:0021762 | |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 3.93e-04 | 46 | 64 | 3 | GO:0031952 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 3.94e-04 | 111 | 64 | 4 | GO:0006942 | |
| GeneOntologyBiologicalProcess | action potential | 4.00e-04 | 201 | 64 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | cytokinesis | 4.28e-04 | 204 | 64 | 5 | GO:0000910 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 5.65e-04 | 52 | 64 | 3 | GO:0010799 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 5.67e-04 | 217 | 64 | 5 | GO:0097553 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 5.79e-04 | 218 | 64 | 5 | GO:1903169 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 5.82e-04 | 611 | 64 | 8 | GO:0045859 | |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 6.74e-04 | 128 | 64 | 4 | GO:0035303 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 6.94e-04 | 129 | 64 | 4 | GO:0002027 | |
| GeneOntologyBiologicalProcess | negative regulation of cation channel activity | 7.02e-04 | 56 | 64 | 3 | GO:2001258 | |
| GeneOntologyBiologicalProcess | dephosphorylation | 7.16e-04 | 347 | 64 | 6 | GO:0016311 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 7.49e-04 | 350 | 64 | 6 | GO:0045860 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 9.46e-04 | 62 | 64 | 3 | GO:0035306 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 1.19e-03 | 256 | 64 | 5 | GO:0032412 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 1.23e-03 | 686 | 64 | 8 | GO:0043549 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.25e-03 | 259 | 64 | 5 | GO:0051651 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 1.28e-03 | 152 | 64 | 4 | GO:0000086 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 1.29e-03 | 69 | 64 | 3 | GO:1903170 | |
| GeneOntologyBiologicalProcess | positive regulation of non-canonical Wnt signaling pathway | 1.40e-03 | 18 | 64 | 2 | GO:2000052 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 1.41e-03 | 266 | 64 | 5 | GO:0043270 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 1.41e-03 | 266 | 64 | 5 | GO:0019722 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 1.41e-03 | 266 | 64 | 5 | GO:0022898 | |
| GeneOntologyBiologicalProcess | neural nucleus development | 1.46e-03 | 72 | 64 | 3 | GO:0048857 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 1.47e-03 | 158 | 64 | 4 | GO:0030177 | |
| GeneOntologyBiologicalProcess | axonal transport of mitochondrion | 1.57e-03 | 19 | 64 | 2 | GO:0019896 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 1.58e-03 | 273 | 64 | 5 | GO:0034764 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.59e-03 | 405 | 64 | 6 | GO:0033674 | |
| GeneOntologyBiologicalProcess | axonal transport | 1.64e-03 | 75 | 64 | 3 | GO:0098930 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 1.81e-03 | 167 | 64 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | 1.81e-03 | 1088 | 64 | 10 | GO:0051248 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | EPM2A HDAC6 PIK3R6 CALM1 CALM2 CALM3 HRG XIAP TNIP1 PLEC XRCC5 MAPK8IP3 | 1.87e-03 | 1488 | 64 | 12 | GO:0031399 |
| GeneOntologyBiologicalProcess | axon guidance | 1.91e-03 | 285 | 64 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.94e-03 | 286 | 64 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 1.97e-03 | 171 | 64 | 4 | GO:0044839 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | 2.31e-03 | 937 | 64 | 9 | GO:0031401 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 2.35e-03 | 299 | 64 | 5 | GO:0032409 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | EPM2A HDAC6 PIK3R6 CALM1 CALM2 CALM3 HRG PLEC XRCC5 MAPK8IP3 | 2.43e-03 | 1133 | 64 | 10 | GO:0001932 |
| GeneOntologyBiologicalProcess | negative regulation of ion transmembrane transporter activity | 2.51e-03 | 87 | 64 | 3 | GO:0032413 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 2.85e-03 | 91 | 64 | 3 | GO:0140115 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transport | 2.94e-03 | 92 | 64 | 3 | GO:0051926 | |
| GeneOntologyCellularComponent | calyx of Held | 1.73e-04 | 36 | 63 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | laminin complex | 3.96e-04 | 10 | 63 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 4.49e-04 | 934 | 63 | 10 | GO:0048471 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 7.53e-04 | 238 | 63 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | growth cone | 8.58e-04 | 245 | 63 | 5 | GO:0030426 | |
| GeneOntologyCellularComponent | sarcomere | 9.22e-04 | 249 | 63 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | sperm midpiece | 9.53e-04 | 64 | 63 | 3 | GO:0097225 | |
| GeneOntologyCellularComponent | site of polarized growth | 9.90e-04 | 253 | 63 | 5 | GO:0030427 | |
| GeneOntologyCellularComponent | microtubule | 1.08e-03 | 533 | 63 | 7 | GO:0005874 | |
| GeneOntologyCellularComponent | myofibril | 1.39e-03 | 273 | 63 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.40e-03 | 73 | 63 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | microtubule organizing center | 1.65e-03 | 919 | 63 | 9 | GO:0005815 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.81e-03 | 290 | 63 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | costamere | 1.99e-03 | 22 | 63 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | centrosome | 2.11e-03 | 770 | 63 | 8 | GO:0005813 | |
| GeneOntologyCellularComponent | spindle microtubule | 2.23e-03 | 86 | 63 | 3 | GO:0005876 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 2.62e-03 | 91 | 63 | 3 | GO:0008076 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.25e-03 | 332 | 63 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | spindle pole | 3.41e-03 | 205 | 63 | 4 | GO:0000922 | |
| GeneOntologyCellularComponent | potassium channel complex | 3.83e-03 | 104 | 63 | 3 | GO:0034705 | |
| GeneOntologyCellularComponent | sperm flagellum | 3.97e-03 | 214 | 63 | 4 | GO:0036126 | |
| GeneOntologyCellularComponent | myelin sheath | 4.17e-03 | 217 | 63 | 4 | GO:0043209 | |
| GeneOntologyCellularComponent | motile cilium | 4.31e-03 | 355 | 63 | 5 | GO:0031514 | |
| GeneOntologyCellularComponent | cytoplasmic region | 4.57e-03 | 360 | 63 | 5 | GO:0099568 | |
| HumanPheno | Abnormal cardiac exercise stress test | 1.96e-06 | 19 | 26 | 4 | HP:0500018 | |
| HumanPheno | Torsade de pointes | 6.28e-06 | 25 | 26 | 4 | HP:0001664 | |
| HumanPheno | Prolonged QTc interval | 1.16e-05 | 29 | 26 | 4 | HP:0005184 | |
| HumanPheno | Sinus bradycardia | 1.34e-05 | 30 | 26 | 4 | HP:0001688 | |
| HumanPheno | Polymorphic ventricular tachycardia | 1.38e-05 | 10 | 26 | 3 | HP:0031677 | |
| HumanPheno | 2:1 atrioventricular block | 2.51e-05 | 2 | 26 | 2 | HP:0034305 | |
| HumanPheno | Abnormal T-wave | 3.14e-05 | 37 | 26 | 4 | HP:0005135 | |
| HumanPheno | Second degree atrioventricular block | 5.16e-05 | 15 | 26 | 3 | HP:0011706 | |
| HumanPheno | T-wave alternans | 7.49e-05 | 3 | 26 | 2 | HP:0012266 | |
| HumanPheno | Bradycardia | 1.14e-04 | 98 | 26 | 5 | HP:0001662 | |
| HumanPheno | Prolonged QT interval | 1.42e-04 | 54 | 26 | 4 | HP:0001657 | |
| HumanPheno | Ventricular fibrillation | 2.59e-04 | 63 | 26 | 4 | HP:0001663 | |
| HumanPheno | Abnormal QT interval | 2.75e-04 | 64 | 26 | 4 | HP:0031547 | |
| MousePheno | sinus bradycardia | 1.92e-05 | 14 | 54 | 3 | MP:0010637 | |
| Domain | EF_Hand_1_Ca_BS | 6.94e-09 | 175 | 63 | 9 | IPR018247 | |
| Domain | EF_HAND_1 | 2.64e-08 | 204 | 63 | 9 | PS00018 | |
| Domain | EF-hand_1 | 4.24e-08 | 152 | 63 | 8 | PF00036 | |
| Domain | EFh | 5.73e-08 | 158 | 63 | 8 | SM00054 | |
| Domain | EF_HAND_2 | 7.68e-08 | 231 | 63 | 9 | PS50222 | |
| Domain | EF_hand_dom | 7.97e-08 | 232 | 63 | 9 | IPR002048 | |
| Domain | Ca-bd_2 | 1.46e-07 | 4 | 63 | 3 | IPR015754 | |
| Domain | EF-hand_7 | 4.10e-07 | 85 | 63 | 6 | PF13499 | |
| Domain | EF-hand-dom_pair | 4.82e-07 | 287 | 63 | 9 | IPR011992 | |
| Domain | - | 2.73e-05 | 261 | 63 | 7 | 1.10.238.10 | |
| Domain | - | 1.11e-04 | 5 | 63 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 1.11e-04 | 5 | 63 | 2 | IPR016194 | |
| Domain | LAMININ_IVA | 3.09e-04 | 8 | 63 | 2 | PS51115 | |
| Domain | Laminin_B | 3.09e-04 | 8 | 63 | 2 | PF00052 | |
| Domain | LamB | 3.09e-04 | 8 | 63 | 2 | SM00281 | |
| Domain | Laminin_IV | 3.09e-04 | 8 | 63 | 2 | IPR000034 | |
| Domain | - | 1.78e-03 | 71 | 63 | 3 | 1.10.418.10 | |
| Domain | CH-domain | 2.08e-03 | 75 | 63 | 3 | IPR001715 | |
| Domain | EGF_LAM_2 | 4.58e-03 | 30 | 63 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 4.58e-03 | 30 | 63 | 2 | PS01248 | |
| Domain | Laminin_EGF | 6.20e-03 | 35 | 63 | 2 | PF00053 | |
| Domain | EGF_Lam | 6.20e-03 | 35 | 63 | 2 | SM00180 | |
| Domain | Laminin_EGF | 7.28e-03 | 38 | 63 | 2 | IPR002049 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.93e-07 | 5 | 49 | 3 | MM14493 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 7.84e-07 | 6 | 49 | 3 | MM15662 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 7.84e-07 | 6 | 49 | 3 | MM14494 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 1.37e-06 | 7 | 49 | 3 | MM1357 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 3.27e-06 | 9 | 49 | 3 | M3412 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 4.66e-06 | 10 | 49 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 4.66e-06 | 10 | 49 | 3 | M47954 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 6.39e-06 | 11 | 49 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 6.39e-06 | 11 | 49 | 3 | M47958 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 8.49e-06 | 12 | 49 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 8.49e-06 | 12 | 49 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 8.49e-06 | 12 | 49 | 3 | M47956 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 1.10e-05 | 13 | 49 | 3 | MM15078 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 1.40e-05 | 14 | 49 | 3 | MM1473 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.40e-05 | 14 | 49 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.40e-05 | 14 | 49 | 3 | M47388 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.40e-05 | 14 | 49 | 3 | MM15391 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.40e-05 | 14 | 49 | 3 | MM15052 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.58e-05 | 44 | 49 | 4 | M39845 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.74e-05 | 15 | 49 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 1.74e-05 | 15 | 49 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 1.74e-05 | 15 | 49 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.74e-05 | 15 | 49 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 1.74e-05 | 15 | 49 | 3 | MM14795 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 2.14e-05 | 16 | 49 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 2.14e-05 | 16 | 49 | 3 | M47449 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.14e-05 | 16 | 49 | 3 | MM14492 | |
| Pathway | KEGG_MELANOGENESIS | 2.54e-05 | 101 | 49 | 5 | M7761 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 2.59e-05 | 17 | 49 | 3 | M2349 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 2.59e-05 | 17 | 49 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.59e-05 | 17 | 49 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 2.59e-05 | 17 | 49 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 2.59e-05 | 17 | 49 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 2.59e-05 | 17 | 49 | 3 | MM1372 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 3.10e-05 | 18 | 49 | 3 | M3430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 3.10e-05 | 18 | 49 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 3.10e-05 | 18 | 49 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 3.10e-05 | 18 | 49 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 3.10e-05 | 18 | 49 | 3 | MM1385 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 3.68e-05 | 19 | 49 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 3.68e-05 | 19 | 49 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 3.68e-05 | 19 | 49 | 3 | M47957 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 4.32e-05 | 20 | 49 | 3 | MM1445 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 5.02e-05 | 21 | 49 | 3 | M47542 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 5.02e-05 | 21 | 49 | 3 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 5.80e-05 | 22 | 49 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 5.80e-05 | 22 | 49 | 3 | MM15519 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 6.66e-05 | 23 | 49 | 3 | M47512 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 6.66e-05 | 23 | 49 | 3 | MM15222 | |
| Pathway | KEGG_GLIOMA | 7.46e-05 | 65 | 49 | 4 | M1835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 7.59e-05 | 24 | 49 | 3 | M47509 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 8.60e-05 | 25 | 49 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 8.60e-05 | 25 | 49 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 8.60e-05 | 25 | 49 | 3 | M47511 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 8.60e-05 | 25 | 49 | 3 | MM15574 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 8.60e-05 | 25 | 49 | 3 | M1547 | |
| Pathway | WP_MELANOMA | 8.91e-05 | 68 | 49 | 4 | M39811 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 9.70e-05 | 26 | 49 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 9.70e-05 | 26 | 49 | 3 | M17941 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 9.70e-05 | 26 | 49 | 3 | MM1431 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 9.70e-05 | 26 | 49 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 9.70e-05 | 26 | 49 | 3 | MM1371 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 9.98e-05 | 70 | 49 | 4 | M3115 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 1.09e-04 | 27 | 49 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 1.09e-04 | 27 | 49 | 3 | M7739 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.09e-04 | 27 | 49 | 3 | MM15053 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.22e-04 | 28 | 49 | 3 | MM14711 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 1.22e-04 | 28 | 49 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.22e-04 | 28 | 49 | 3 | M47508 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 1.35e-04 | 29 | 49 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 1.35e-04 | 29 | 49 | 3 | M13494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.35e-04 | 29 | 49 | 3 | MM15219 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 1.35e-04 | 29 | 49 | 3 | MM1495 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.38e-04 | 76 | 49 | 4 | M9052 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.50e-04 | 30 | 49 | 3 | MM15170 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 1.50e-04 | 30 | 49 | 3 | M9664 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 1.66e-04 | 31 | 49 | 3 | MM14896 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 1.82e-04 | 32 | 49 | 3 | MM1355 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.82e-04 | 32 | 49 | 3 | MM15143 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.00e-04 | 33 | 49 | 3 | M9494 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 2.19e-04 | 34 | 49 | 3 | M10287 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 2.19e-04 | 34 | 49 | 3 | MM15985 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 2.19e-04 | 34 | 49 | 3 | MM1399 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.39e-04 | 35 | 49 | 3 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.39e-04 | 35 | 49 | 3 | MM15109 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 2.39e-04 | 35 | 49 | 3 | MM15114 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 3.30e-04 | 39 | 49 | 3 | M1908 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.30e-04 | 39 | 49 | 3 | MM14496 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 3.30e-04 | 39 | 49 | 3 | MM1397 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 3.56e-04 | 40 | 49 | 3 | M39595 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 4.11e-04 | 101 | 49 | 4 | M1979 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 4.12e-04 | 42 | 49 | 3 | MM1504 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 4.73e-04 | 44 | 49 | 3 | M19784 | |
| Pathway | REACTOME_CA2_PATHWAY | 5.05e-04 | 45 | 49 | 3 | MM15040 | |
| Pathway | REACTOME_RAS_PROCESSING | 5.05e-04 | 45 | 49 | 3 | MM15671 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 6.12e-04 | 48 | 49 | 3 | MM14589 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 6.28e-04 | 113 | 49 | 4 | M16817 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M158 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 6.38e-04 | 11 | 49 | 2 | M27372 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 6.50e-04 | 49 | 49 | 3 | MM1442 | |
| Pubmed | 5.20e-11 | 5 | 64 | 4 | 15140941 | ||
| Pubmed | 5.20e-11 | 5 | 64 | 4 | 25703379 | ||
| Pubmed | 5.20e-11 | 5 | 64 | 4 | 18570893 | ||
| Pubmed | Membrane targeting of the EF-hand containing calcium-sensing proteins CaBP7 and CaBP8. | 3.63e-10 | 7 | 64 | 4 | 19338761 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 29932249 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 5.94e-09 | 3 | 64 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 5.94e-09 | 3 | 64 | 3 | 9923700 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 5.94e-09 | 3 | 64 | 3 | 23893133 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 18940602 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 25268113 | ||
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 5.94e-09 | 3 | 64 | 3 | 8573130 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 19651602 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 10899953 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 26969752 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 5.94e-09 | 3 | 64 | 3 | 11807546 | |
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 5.94e-09 | 3 | 64 | 3 | 9278050 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 15719022 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 8312049 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 5.94e-09 | 3 | 64 | 3 | 11847276 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 10416864 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 7828884 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 8862395 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 37380439 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 5.94e-09 | 3 | 64 | 3 | 11710561 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 5.94e-09 | 3 | 64 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 5.94e-09 | 3 | 64 | 3 | 3384819 | |
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 5.94e-09 | 3 | 64 | 3 | 2469574 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 21799007 | ||
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 5.94e-09 | 3 | 64 | 3 | 15632291 | |
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 5.94e-09 | 3 | 64 | 3 | 20956522 | |
| Pubmed | UBE3B Is a Calmodulin-regulated, Mitochondrion-associated E3 Ubiquitin Ligase. | 5.94e-09 | 3 | 64 | 3 | 28003368 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 5.94e-09 | 3 | 64 | 3 | 18786401 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 11072229 | ||
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 5.94e-09 | 3 | 64 | 3 | 8631777 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 18553937 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 16229872 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 14978283 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 15063758 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 5.94e-09 | 3 | 64 | 3 | 11054265 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 33191766 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 8226798 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 5.94e-09 | 3 | 64 | 3 | 17582331 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 2.37e-08 | 4 | 64 | 3 | 14960328 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 22405011 | ||
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 2.37e-08 | 4 | 64 | 3 | 7607248 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 27516456 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 2.37e-08 | 4 | 64 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 2.37e-08 | 4 | 64 | 3 | 11807557 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 11286509 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 20953164 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 2.37e-08 | 4 | 64 | 3 | 23040497 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 19855925 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 16299511 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 2.37e-08 | 4 | 64 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 2.37e-08 | 4 | 64 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 2.37e-08 | 4 | 64 | 3 | 8780394 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 19279214 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 25437912 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 2.37e-08 | 4 | 64 | 3 | 15499021 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 10692436 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 2.37e-08 | 4 | 64 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 2.37e-08 | 4 | 64 | 3 | 20103772 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 16478480 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 2.37e-08 | 4 | 64 | 3 | 16127172 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 9096366 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 12577052 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 20226167 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 2.37e-08 | 4 | 64 | 3 | 22067155 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 25441029 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 10823944 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 11278607 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 16505387 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 26164367 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 2.37e-08 | 4 | 64 | 3 | 25519244 | |
| Pubmed | 3.96e-08 | 19 | 64 | 4 | 20301308 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 27165696 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 11981030 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 12034722 | ||
| Pubmed | Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin. | 5.93e-08 | 5 | 64 | 3 | 11741295 | |
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 32522888 | ||
| Pubmed | Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin. | 5.93e-08 | 5 | 64 | 3 | 10880439 | |
| Pubmed | Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. | 5.93e-08 | 5 | 64 | 3 | 19632986 | |
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 3111527 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 17719545 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 35568036 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 9242710 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 25232683 | ||
| Pubmed | Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B. | 5.93e-08 | 5 | 64 | 3 | 20708613 | |
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 22705208 | ||
| Pubmed | Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis. | 5.93e-08 | 5 | 64 | 3 | 23446637 | |
| Interaction | PPP3R1 interactions | 2.15e-09 | 69 | 64 | 7 | int:PPP3R1 | |
| Interaction | MYO18A interactions | HDAC6 CALM1 LMO7 CALM3 WASHC5 SHMT2 TNIP1 ARPC5L PRKCSH PLEC | 3.76e-08 | 303 | 64 | 10 | int:MYO18A |
| Interaction | C11orf65 interactions | 6.47e-08 | 13 | 64 | 4 | int:C11orf65 | |
| Interaction | ZNF280A interactions | 1.64e-07 | 16 | 64 | 4 | int:ZNF280A | |
| Interaction | MYO1E interactions | 2.43e-07 | 202 | 64 | 8 | int:MYO1E | |
| Interaction | IQGAP1 interactions | HDAC6 CALM1 CALM2 LMO7 CALM3 CALML3 TNIP1 ARPC5L ZC3H18 PLEC RAD54L2 RHOF | 2.96e-07 | 591 | 64 | 12 | int:IQGAP1 |
| Interaction | UBE3B interactions | 3.81e-07 | 47 | 64 | 5 | int:UBE3B | |
| Interaction | SPATA17 interactions | 1.06e-06 | 7 | 64 | 3 | int:SPATA17 | |
| Interaction | MYL6B interactions | 1.20e-06 | 108 | 64 | 6 | int:MYL6B | |
| Interaction | DOCK7 interactions | 1.37e-06 | 254 | 64 | 8 | int:DOCK7 | |
| Interaction | KCNN1 interactions | 1.69e-06 | 8 | 64 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 1.69e-06 | 8 | 64 | 3 | int:ARPP21 | |
| Interaction | MYO1D interactions | 2.69e-06 | 194 | 64 | 7 | int:MYO1D | |
| Interaction | ANK3 interactions | 3.40e-06 | 201 | 64 | 7 | int:ANK3 | |
| Interaction | IQCG interactions | 3.61e-06 | 10 | 64 | 3 | int:IQCG | |
| Interaction | CALM2 interactions | 3.99e-06 | 206 | 64 | 7 | int:CALM2 | |
| Interaction | NSMF interactions | 4.50e-06 | 35 | 64 | 4 | int:NSMF | |
| Interaction | PPP3CC interactions | 4.86e-06 | 78 | 64 | 5 | int:PPP3CC | |
| Interaction | CAMKMT interactions | 5.05e-06 | 36 | 64 | 4 | int:CAMKMT | |
| Interaction | ITPR1 interactions | 5.66e-06 | 141 | 64 | 6 | int:ITPR1 | |
| Interaction | VIM interactions | HDAC6 LMO7 CALM3 RRP9 POLR1C EIF5B XIAP TNIP1 ZC3H18 KIFC3 PLEC CIC | 7.28e-06 | 804 | 64 | 12 | int:VIM |
| Interaction | PHKG2 interactions | 1.04e-05 | 91 | 64 | 5 | int:PHKG2 | |
| Interaction | RAP2A interactions | 1.04e-05 | 91 | 64 | 5 | int:RAP2A | |
| Interaction | IQSEC2 interactions | 1.14e-05 | 44 | 64 | 4 | int:IQSEC2 | |
| Interaction | DDX41 interactions | 1.44e-05 | 166 | 64 | 6 | int:DDX41 | |
| Interaction | MYO5B interactions | 1.90e-05 | 103 | 64 | 5 | int:MYO5B | |
| Interaction | UNC13B interactions | 2.23e-05 | 52 | 64 | 4 | int:UNC13B | |
| Interaction | OBSL1 interactions | CALM1 CALM3 CALML3 RRP9 NEMF EIF5B SHMT2 TNIP1 PLEC XRCC5 SPEN RCAN3 | 2.30e-05 | 902 | 64 | 12 | int:OBSL1 |
| Interaction | LRCH3 interactions | 2.39e-05 | 108 | 64 | 5 | int:LRCH3 | |
| Interaction | CAMTA2 interactions | 2.41e-05 | 18 | 64 | 3 | int:CAMTA2 | |
| Interaction | FMNL1 interactions | 2.50e-05 | 109 | 64 | 5 | int:FMNL1 | |
| Interaction | TNNI1 interactions | 2.60e-05 | 54 | 64 | 4 | int:TNNI1 | |
| Interaction | STMN3 interactions | 2.79e-05 | 55 | 64 | 4 | int:STMN3 | |
| Interaction | PRPF8 interactions | HDAC6 EIF5B SHMT2 TNIP1 ZNF830 ZC3H18 PLEC XRCC5 SPEN CWF19L1 CIC | 2.96e-05 | 776 | 64 | 11 | int:PRPF8 |
| Interaction | SPATC1L interactions | 3.00e-05 | 56 | 64 | 4 | int:SPATC1L | |
| Interaction | MYO1C interactions | 3.57e-05 | 397 | 64 | 8 | int:MYO1C | |
| Interaction | BTF3 interactions | NAA35 ANK2 CALM1 CALM2 LMO7 CALM3 CALML3 TNIP1 ARPC5L PLEC XRCC5 | 3.87e-05 | 799 | 64 | 11 | int:BTF3 |
| Interaction | MAP7D3 interactions | 4.46e-05 | 123 | 64 | 5 | int:MAP7D3 | |
| Interaction | MYL1 interactions | 4.49e-05 | 62 | 64 | 4 | int:MYL1 | |
| Interaction | MYO5A interactions | 4.60e-05 | 204 | 64 | 6 | int:MYO5A | |
| Interaction | LIG3 interactions | 4.99e-05 | 207 | 64 | 6 | int:LIG3 | |
| Interaction | C9orf40 interactions | 5.17e-05 | 23 | 64 | 3 | int:C9orf40 | |
| Interaction | IK interactions | 6.16e-05 | 215 | 64 | 6 | int:IK | |
| Interaction | LIMA1 interactions | 6.16e-05 | 429 | 64 | 8 | int:LIMA1 | |
| Interaction | CAPZA2 interactions | 6.26e-05 | 430 | 64 | 8 | int:CAPZA2 | |
| Interaction | CUL7 interactions | CALM1 CALM2 CALM3 RRP9 EIF5B SHMT2 ZC3H18 PRKCSH PLEC XRCC5 SPEN | 6.42e-05 | 845 | 64 | 11 | int:CUL7 |
| Interaction | PHKA2 interactions | 6.85e-05 | 69 | 64 | 4 | int:PHKA2 | |
| Interaction | RALA interactions | 7.20e-05 | 136 | 64 | 5 | int:RALA | |
| Interaction | IQCN interactions | 7.25e-05 | 70 | 64 | 4 | int:IQCN | |
| Interaction | KIF23 interactions | HDAC6 CALM1 CALM3 CALML3 POLR1C EIF5B SHMT2 TNIP1 ZC3H18 KIFC3 PLEC XRCC5 | 8.41e-05 | 1031 | 64 | 12 | int:KIF23 |
| Interaction | MYO10 interactions | 8.54e-05 | 141 | 64 | 5 | int:MYO10 | |
| Interaction | NACA interactions | 9.82e-05 | 234 | 64 | 6 | int:NACA | |
| Interaction | SUMO2 interactions | 9.87e-05 | 591 | 64 | 9 | int:SUMO2 | |
| Interaction | ECT2 interactions | CALM1 LMO7 CALML3 RRP9 EIF5B SHMT2 TNIP1 KIFC3 PLEC XRCC5 NLRP5 | 9.89e-05 | 887 | 64 | 11 | int:ECT2 |
| Interaction | CALM3 interactions | 1.05e-04 | 343 | 64 | 7 | int:CALM3 | |
| Interaction | PPEF2 interactions | 1.05e-04 | 29 | 64 | 3 | int:PPEF2 | |
| Interaction | YARS1 interactions | 1.11e-04 | 149 | 64 | 5 | int:YARS1 | |
| Interaction | CAMK2G interactions | 1.13e-04 | 240 | 64 | 6 | int:CAMK2G | |
| Interaction | ESCO1 interactions | 1.17e-04 | 30 | 64 | 3 | int:ESCO1 | |
| Interaction | EIF2S2 interactions | 1.32e-04 | 247 | 64 | 6 | int:EIF2S2 | |
| Interaction | NKX2-5 interactions | 1.34e-04 | 82 | 64 | 4 | int:NKX2-5 | |
| Interaction | SH2B1 interactions | 1.42e-04 | 32 | 64 | 3 | int:SH2B1 | |
| Interaction | KCNQ2 interactions | 1.47e-04 | 84 | 64 | 4 | int:KCNQ2 | |
| Interaction | MYL6 interactions | 1.57e-04 | 255 | 64 | 6 | int:MYL6 | |
| Interaction | IQCB1 interactions | 1.68e-04 | 370 | 64 | 7 | int:IQCB1 | |
| Interaction | CEP97 interactions | 1.79e-04 | 165 | 64 | 5 | int:CEP97 | |
| Interaction | DENND4A interactions | 1.93e-04 | 90 | 64 | 4 | int:DENND4A | |
| Interaction | FLNA interactions | 1.97e-04 | 648 | 64 | 9 | int:FLNA | |
| Interaction | SCRIB interactions | 1.97e-04 | 266 | 64 | 6 | int:SCRIB | |
| Interaction | CFL1 interactions | 2.11e-04 | 384 | 64 | 7 | int:CFL1 | |
| Interaction | SLC25A1 interactions | 2.14e-04 | 270 | 64 | 6 | int:SLC25A1 | |
| Interaction | IQCE interactions | 2.20e-04 | 37 | 64 | 3 | int:IQCE | |
| Interaction | PRC1 interactions | CALM1 LMO7 RRP9 POLR1C EIF5B LAMC2 TNIP1 ZC3H18 PLEC XRCC5 SPEN | 2.23e-04 | 973 | 64 | 11 | int:PRC1 |
| Interaction | DPM1 interactions | 2.23e-04 | 173 | 64 | 5 | int:DPM1 | |
| Interaction | C1QB interactions | 2.28e-04 | 94 | 64 | 4 | int:C1QB | |
| Interaction | ACTR1A interactions | 2.32e-04 | 274 | 64 | 6 | int:ACTR1A | |
| Interaction | POC5 interactions | 2.37e-04 | 95 | 64 | 4 | int:POC5 | |
| Interaction | LMO7 interactions | 2.48e-04 | 177 | 64 | 5 | int:LMO7 | |
| Interaction | GPC1 interactions | 2.61e-04 | 179 | 64 | 5 | int:GPC1 | |
| Interaction | MYO6 interactions | 2.62e-04 | 398 | 64 | 7 | int:MYO6 | |
| Interaction | PPP3CB interactions | 2.67e-04 | 98 | 64 | 4 | int:PPP3CB | |
| Interaction | ACTN4 interactions | 2.70e-04 | 400 | 64 | 7 | int:ACTN4 | |
| Interaction | CABP5 interactions | 2.78e-04 | 40 | 64 | 3 | int:CABP5 | |
| Interaction | RPS15A interactions | 2.83e-04 | 403 | 64 | 7 | int:RPS15A | |
| Interaction | QSER1 interactions | 2.89e-04 | 100 | 64 | 4 | int:QSER1 | |
| Interaction | SUPT5H interactions | 3.05e-04 | 408 | 64 | 7 | int:SUPT5H | |
| Interaction | KIF1A interactions | 3.11e-04 | 102 | 64 | 4 | int:KIF1A | |
| Interaction | ARPC2 interactions | 3.19e-04 | 187 | 64 | 5 | int:ARPC2 | |
| Interaction | MITD1 interactions | 3.21e-04 | 42 | 64 | 3 | int:MITD1 | |
| Interaction | PHKA1 interactions | 3.44e-04 | 43 | 64 | 3 | int:PHKA1 | |
| Interaction | SPTBN1 interactions | 3.68e-04 | 421 | 64 | 7 | int:SPTBN1 | |
| Interaction | GSPT2 interactions | 3.74e-04 | 107 | 64 | 4 | int:GSPT2 | |
| Interaction | DDX17 interactions | 3.95e-04 | 426 | 64 | 7 | int:DDX17 | |
| Interaction | ZNF207 interactions | 4.29e-04 | 111 | 64 | 4 | int:ZNF207 | |
| Interaction | VPS13A interactions | 4.44e-04 | 112 | 64 | 4 | int:VPS13A | |
| Interaction | MYO9B interactions | 4.59e-04 | 113 | 64 | 4 | int:MYO9B | |
| Interaction | CAMKK1 interactions | 4.77e-04 | 48 | 64 | 3 | int:CAMKK1 | |
| Interaction | AVPI1 interactions | 4.77e-04 | 48 | 64 | 3 | int:AVPI1 | |
| Interaction | SYNE3 interactions | 5.06e-04 | 444 | 64 | 7 | int:SYNE3 | |
| Interaction | MCM3AP interactions | 5.24e-04 | 117 | 64 | 4 | int:MCM3AP | |
| Cytoband | 12q24.31 | 1.97e-04 | 80 | 64 | 3 | 12q24.31 | |
| Cytoband | 3p21.2 | 3.22e-04 | 19 | 64 | 2 | 3p21.2 | |
| Cytoband | 5q13.3 | 1.10e-03 | 35 | 64 | 2 | 5q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 2.73e-03 | 415 | 64 | 4 | chr12q24 | |
| GeneFamily | EF-hand domain containing | CAPN9 CABP1 CABP2 CABP5 CABP7 CALM1 CALM2 CALM3 CALML3 PRKCSH | 5.81e-11 | 219 | 42 | 10 | 863 |
| GeneFamily | Laminin subunits | 3.43e-04 | 12 | 42 | 2 | 626 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | CALM1 CALM2 CALM3 RRP9 UBE3B EIF5B XIAP ARPC5L ZC3H18 CWF19L1 CHRNA5 | 3.09e-06 | 792 | 64 | 11 | M12113 |
| Coexpression | LEIN_PONS_MARKERS | 3.62e-06 | 95 | 64 | 5 | MM718 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 4.88e-06 | 46 | 64 | 4 | MM670 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 9.21e-06 | 17 | 64 | 3 | MM686 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP | 2.37e-05 | 23 | 64 | 3 | MM694 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 4.45e-05 | 80 | 64 | 4 | MM1285 | |
| Coexpression | GUO_HEX_TARGETS_UP | 4.45e-05 | 80 | 64 | 4 | MM626 | |
| Coexpression | EIF4E_DN | 1.06e-04 | 100 | 64 | 4 | M2790 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP | 1.30e-04 | 200 | 64 | 5 | M9470 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 1.30e-04 | 200 | 64 | 5 | M6248 | |
| Coexpression | GSE27786_NKTCELL_VS_MONO_MAC_UP | 1.30e-04 | 200 | 64 | 5 | M4870 | |
| Coexpression | GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN | 1.30e-04 | 200 | 64 | 5 | M6774 | |
| ToppCell | severe_influenza-gd_T|severe_influenza / disease group, cell group and cell class (v2) | 2.49e-07 | 182 | 64 | 6 | b6b44c90af3f0c0dddb2b171087865d8c15a3973 | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.21e-07 | 190 | 64 | 6 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK|ICU-NoSEP / Disease, Lineage and Cell Type | 3.62e-07 | 194 | 64 | 6 | 090edfc884655e5ab38b027c6e1a5aa809ebb19d | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK|ICU-NoSEP / Disease, condition lineage and cell class | 4.33e-07 | 200 | 64 | 6 | 6d1e927c4498dc8a6152c211d414f719d9c1f436 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.27e-06 | 181 | 64 | 5 | ddbfa99b8906fbf2d070f87d905bda1af2200601 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.14e-06 | 191 | 64 | 5 | 82f4a4b0c35638ca4b2c428d0bb946ea95c1001b | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_TEM|URO / Disease, Lineage and Cell Type | 8.35e-06 | 192 | 64 | 5 | 31b6d068f7adc6952c4cf625df851a10cb1b00c9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.35e-06 | 192 | 64 | 5 | fd7f034f0d5a5d577dc9e26a15856f5defbdef43 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK|Leuk-UTI / Disease, Lineage and Cell Type | 8.35e-06 | 192 | 64 | 5 | b3e1c8a260782c2b79e3bda6557542055edde6fb | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.56e-06 | 193 | 64 | 5 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.56e-06 | 193 | 64 | 5 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 8.56e-06 | 193 | 64 | 5 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | 8.56e-06 | 193 | 64 | 5 | f110f86db305e41639087f5b1a2dff103c07adf0 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 8.78e-06 | 194 | 64 | 5 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | URO-Lymphocyte-T_NK|URO / Disease, Lineage and Cell Type | 8.78e-06 | 194 | 64 | 5 | 4806c07dcf1bc6d9591548382b77817568eb16b6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 9.00e-06 | 195 | 64 | 5 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | COVID-CD4-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 9.23e-06 | 196 | 64 | 5 | a4fb3abf3c38928da9e8281dee8a304e8fd55eab | |
| ToppCell | Control-Lymphocyte-T_NK-NK|Control / Disease, Lineage and Cell Type | 9.23e-06 | 196 | 64 | 5 | 65838fddc920cdcecefe823f3ce1c95a7e50e82b | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK|ICU-NoSEP / Disease, Lineage and Cell Type | 9.46e-06 | 197 | 64 | 5 | 951bb4c1e6f5c5fd7e7d58b36eb3f31e9201fb66 | |
| ToppCell | COVID-CD4|COVID / Condition, Cell_class and T cell subcluster | 9.69e-06 | 198 | 64 | 5 | 3b72d3fa96f8cda528c483afdff391385113080d | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.69e-06 | 198 | 64 | 5 | 0bf7a339e9ee384f1a198ca7c1c51b9a54a7b99f | |
| ToppCell | URO-Lymphocyte-T_NK-NK|URO / Disease, Lineage and Cell Type | 9.69e-06 | 198 | 64 | 5 | 2ccff882aafabf041df15b31d9abc50dcbc2696e | |
| ToppCell | Healthy-NK|World / disease group, cell group and cell class | 9.69e-06 | 198 | 64 | 5 | 517e49669e13e428aa66081a0ce83c30f3b9b08b | |
| ToppCell | Int-URO-Lymphocyte-T_NK|Int-URO / Disease, Lineage and Cell Type | 9.69e-06 | 198 | 64 | 5 | f96491fdd266352f565fb9b303395d13b193cbf8 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK|ICU-SEP / Disease, Lineage and Cell Type | 9.69e-06 | 198 | 64 | 5 | 03c5493faf3a4e09a5c1b1450c4551f12f699298 | |
| ToppCell | Healthy-NK|Healthy / disease group, cell group and cell class | 9.69e-06 | 198 | 64 | 5 | 3402f88ef2f05d61c16cbe61b996bcc8fd119261 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.93e-06 | 199 | 64 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-gd_T|Influenza_Severe / Disease, condition lineage and cell class | 9.93e-06 | 199 | 64 | 5 | b1ecc8aa5a98fe42d678ab07b310d62ebaacdecf | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK|Leuk-UTI / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | 88eba6199fb1edd745ab09216df3d43b27f84c6c | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-NK|ICU-SEP / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | 6813fa6d24950fac22e2b5bb26b64f79214163b6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD8+_Tem|URO / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | e621b46084839700e6dd338fdafc682a07cd698d | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK|ICU-NoSEP / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | 31c06b73292015e69038e52ae67322f458f37c71 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK|URO / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | ef40ed94261bdb79b7bde4196ff08bf327717b6b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.02e-05 | 200 | 64 | 5 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK|Int-URO / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | c40ec12c9174e540de36e5eaf5b8b75688b63a38 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-NK|URO / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | 741c7bad606c7e4d7db57d89aaf4dcf4232fa82a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.02e-05 | 200 | 64 | 5 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-NK|Int-URO / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | 3ae0f3dc4f6c9e0315155de80967134b2c1b3364 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK|ICU-SEP / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | b6df9bf85f564f611010bdabc70f02e2155e62f1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK|Leuk-UTI / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | bb37fed4872e71f413ae7c4aa12586fa31075334 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 116 | 64 | 4 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 155 | 64 | 4 | 550e7e7e52829244ead829e5be010bfdc71e2ba5 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 163 | 64 | 4 | e58863a462cc504bced627f004a47890ee2307ce | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 9.78e-05 | 167 | 64 | 4 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 176 | 64 | 4 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 176 | 64 | 4 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 179 | 64 | 4 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 179 | 64 | 4 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 179 | 64 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | IIH-CD4-exh_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.31e-04 | 180 | 64 | 4 | 31f22960819bfad79cbbd3b10c5dc46d7a47e340 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 181 | 64 | 4 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 181 | 64 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 182 | 64 | 4 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 183 | 64 | 4 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 184 | 64 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 184 | 64 | 4 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | Healthy/Control-CD4+_CTL|Healthy/Control / Disease group and Cell class | 1.42e-04 | 184 | 64 | 4 | 6c6ffa150f81e456f88e9065de90c2dcda417589 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 184 | 64 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 185 | 64 | 4 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-04 | 185 | 64 | 4 | 593eceb3dfcc662c892a840ba29ab687c6886c01 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 185 | 64 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 185 | 64 | 4 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 186 | 64 | 4 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 186 | 64 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 187 | 64 | 4 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TEM|Control / Disease, Lineage and Cell Type | 1.51e-04 | 187 | 64 | 4 | 7fdff970a9397305d0b8194c00a043cc69dcca12 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 187 | 64 | 4 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 188 | 64 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | (0)_NK_CD160pos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.57e-04 | 189 | 64 | 4 | 713991025bb92d38cb0507ff01fd91b48c8af45a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 189 | 64 | 4 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 6b3b42d758b63a0df62310c34fa3bde421c1afd7 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.57e-04 | 189 | 64 | 4 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 344b23d3c47d0665dda1cd4856a5e72f1c28cfb3 | |
| ToppCell | control-CD8+_Tem|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.61e-04 | 190 | 64 | 4 | 1200074e358f164d36bf22800a17ce0fca319560 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 190 | 64 | 4 | c8031df82c3662ce4140c850277987f7210e9bcd | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 1.61e-04 | 190 | 64 | 4 | 519356c4925b5b6647e7d763d4084cd9b2e94f0a | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 190 | 64 | 4 | 4240d52a465bc3f8016834b22a35c44ba2b0a9f4 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD8_TEM|Bac-SEP / Disease, Lineage and Cell Type | 1.64e-04 | 191 | 64 | 4 | 84e3aaed71bd35d73af475d610d1b7e71df9ce3f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 191 | 64 | 4 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | mild_COVID-19-gd_T|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.64e-04 | 191 | 64 | 4 | 0e43c097b92aaa831811d60e033262999e79dcd7 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-04 | 192 | 64 | 4 | 7181174ea95abbeb6628d992b4fbae2f2af5edc6 | |
| ToppCell | control-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.67e-04 | 192 | 64 | 4 | cec6ab5793953072e6b0fee370551224947dd877 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.67e-04 | 192 | 64 | 4 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-04 | 192 | 64 | 4 | a0bd4a0d00246af4f6645e66a0dedfe36882cc60 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.67e-04 | 192 | 64 | 4 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 192 | 64 | 4 | fedff776812c3d040d295ac8c806296e4018b247 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.67e-04 | 192 | 64 | 4 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-CD8_T|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 192 | 64 | 4 | 375817f1b813d7b2be10738c05611e1d1ba23055 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.71e-04 | 193 | 64 | 4 | a77a6018a88291fb466cb9cd13eff4164b0cc8f1 | |
| ToppCell | Control-Lymphocyte-T_NK|Control / Disease, Lineage and Cell Type | 1.71e-04 | 193 | 64 | 4 | eb8b8f6e52fd140fbacf3d6776458c6fc355e120 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 193 | 64 | 4 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-04 | 193 | 64 | 4 | 465061688bc09c6d8adc2f662a385dab8918ebbf | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 193 | 64 | 4 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 193 | 64 | 4 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.71e-04 | 193 | 64 | 4 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.71e-04 | 193 | 64 | 4 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.71e-04 | 193 | 64 | 4 | 81fdb825245cd346bf7277086b95d72a47bded73 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.74e-04 | 194 | 64 | 4 | 6b5be379074241973220f7ef02ef3d5d7d8428ef | |
| Drug | thiomethylpromazine | 5.68e-11 | 4 | 64 | 4 | CID000070583 | |
| Drug | KS-504e | 5.68e-11 | 4 | 64 | 4 | CID000129559 | |
| Drug | KS-504d | 5.68e-11 | 4 | 64 | 4 | CID000129557 | |
| Drug | Archanagelicine | 5.68e-11 | 4 | 64 | 4 | CID003083773 | |
| Drug | Nsc642900 | 5.68e-11 | 4 | 64 | 4 | CID000498959 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 5.68e-11 | 4 | 64 | 4 | CID000127194 | |
| Drug | 85318-25-8 | 5.68e-11 | 4 | 64 | 4 | CID006439702 | |
| Drug | chloraniformethan | 5.68e-11 | 4 | 64 | 4 | CID000030331 | |
| Drug | KS-502 | 5.68e-11 | 4 | 64 | 4 | CID000129242 | |
| Drug | KS-501 | 5.68e-11 | 4 | 64 | 4 | CID000129240 | |
| Drug | 2'-methoxykobusin | 5.68e-11 | 4 | 64 | 4 | CID000637889 | |
| Drug | Ti 233 | 5.68e-11 | 4 | 64 | 4 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 5.68e-11 | 4 | 64 | 4 | CID000080867 | |
| Drug | PS-990 | 5.68e-11 | 4 | 64 | 4 | CID000157810 | |
| Drug | herbarumin III | 5.68e-11 | 4 | 64 | 4 | CID000643678 | |
| Drug | D 890 | 2.83e-10 | 5 | 64 | 4 | CID000134083 | |
| Drug | 4H-1,4-benzothiazin-3-one | 2.83e-10 | 5 | 64 | 4 | CID000021396 | |
| Drug | NSC-36360 | 2.83e-10 | 5 | 64 | 4 | CID000133340 | |
| Drug | C16AA | 2.83e-10 | 5 | 64 | 4 | CID000488017 | |
| Drug | auranthine | 2.83e-10 | 5 | 64 | 4 | CID000130919 | |
| Drug | alpha-CAO | 2.83e-10 | 5 | 64 | 4 | CID000196600 | |
| Drug | Nor2 chlorpromazine | 2.83e-10 | 5 | 64 | 4 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 2.83e-10 | 5 | 64 | 4 | CID005748474 | |
| Drug | Ac-dvda | 2.83e-10 | 5 | 64 | 4 | CID000146768 | |
| Drug | VUF 4576 | 2.83e-10 | 5 | 64 | 4 | CID000132784 | |
| Drug | benziodarone | 8.48e-10 | 6 | 64 | 4 | CID000006237 | |
| Drug | CI-922 | 8.48e-10 | 6 | 64 | 4 | CID000146938 | |
| Drug | caged PE | 8.48e-10 | 6 | 64 | 4 | CID000192405 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 8.48e-10 | 6 | 64 | 4 | CID000004307 | |
| Drug | propyl-methylenedioxyindene | 8.48e-10 | 6 | 64 | 4 | CID000145934 | |
| Drug | 1-(4-pyridyl)ethanol | 1.97e-09 | 7 | 64 | 4 | CID000090919 | |
| Drug | AC1L3PE4 | 1.97e-09 | 7 | 64 | 4 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 1.97e-09 | 7 | 64 | 4 | CID000188375 | |
| Drug | trifluoperazine sulfoxide | 1.97e-09 | 7 | 64 | 4 | CID000159622 | |
| Drug | KHL-8430 | 1.97e-09 | 7 | 64 | 4 | CID000195711 | |
| Drug | CPU57 | 1.97e-09 | 7 | 64 | 4 | CID000195730 | |
| Drug | T 7188 | 1.97e-09 | 7 | 64 | 4 | CID000003311 | |
| Drug | magnesium acetate | 2.25e-09 | 20 | 64 | 5 | CID000008896 | |
| Drug | 3,7,8-trihydroxy-CPZ | 3.94e-09 | 8 | 64 | 4 | CID000467415 | |
| Drug | proxyl nitroxide | 3.94e-09 | 8 | 64 | 4 | CID000076702 | |
| Drug | niludipine | 3.94e-09 | 8 | 64 | 4 | CID000089767 | |
| Drug | KS-504a | 3.94e-09 | 8 | 64 | 4 | CID000129577 | |
| Drug | Ro 22-4839 | 3.94e-09 | 8 | 64 | 4 | CID000065839 | |
| Drug | HT-74 | 3.94e-09 | 8 | 64 | 4 | CID000126681 | |
| Drug | 7,8-diOH-CPZ | 7.08e-09 | 9 | 64 | 4 | CID000159916 | |
| Drug | KS-505a | 7.08e-09 | 9 | 64 | 4 | CID003081782 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 1.18e-08 | 10 | 64 | 4 | CID000152034 | |
| Drug | norchlorpromazine | 1.18e-08 | 10 | 64 | 4 | CID000062875 | |
| Drug | Ins(1,3)P2 | 1.85e-08 | 11 | 64 | 4 | CID000128419 | |
| Drug | indolidan | 1.85e-08 | 11 | 64 | 4 | CID005284402 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 1.85e-08 | 11 | 64 | 4 | CID003035524 | |
| Drug | 4-iodotamoxifen | 1.85e-08 | 11 | 64 | 4 | CID003037006 | |
| Drug | alpha-amyrin linoleate | 1.85e-08 | 11 | 64 | 4 | CID005318324 | |
| Drug | IQ-3 | 1.85e-08 | 11 | 64 | 4 | CID000028212 | |
| Drug | AC1L2NX7 | 1.85e-08 | 11 | 64 | 4 | CID000125056 | |
| Drug | NSC366363 | 2.12e-08 | 3 | 64 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 2.12e-08 | 3 | 64 | 3 | CID004630710 | |
| Drug | tatsiensine | 2.12e-08 | 3 | 64 | 3 | CID000163526 | |
| Drug | delcosine | 2.12e-08 | 3 | 64 | 3 | CID000120726 | |
| Drug | CV-159 | 2.76e-08 | 12 | 64 | 4 | CID000135211 | |
| Drug | tiflucarbine | 2.76e-08 | 12 | 64 | 4 | CID000065677 | |
| Drug | Ant-dATP | 2.76e-08 | 12 | 64 | 4 | CID000131323 | |
| Drug | daurisoline | 3.98e-08 | 13 | 64 | 4 | CID000051106 | |
| Drug | NSC708927 | 3.98e-08 | 13 | 64 | 4 | CID011970115 | |
| Drug | APP 201-533 | 3.98e-08 | 13 | 64 | 4 | CID000133461 | |
| Drug | SC-52458 | 3.98e-08 | 13 | 64 | 4 | CID000132706 | |
| Drug | Hdel sequence | 6.09e-08 | 37 | 64 | 5 | CID000131113 | |
| Drug | dysprosium | 6.19e-08 | 74 | 64 | 6 | CID000023912 | |
| Drug | 9-anthroylcholine | 7.57e-08 | 15 | 64 | 4 | CID000173246 | |
| Drug | CTK0F9956 | 8.46e-08 | 4 | 64 | 3 | CID011779542 | |
| Drug | cloxacepride | 8.46e-08 | 4 | 64 | 3 | CID000068859 | |
| Drug | Roylin | 8.46e-08 | 4 | 64 | 3 | CID000099924 | |
| Drug | fluphenazine-N-mustard | 1.01e-07 | 16 | 64 | 4 | CID000134141 | |
| Drug | Org 30029 | 1.01e-07 | 16 | 64 | 4 | CID006336059 | |
| Drug | NSC-114340 | 1.01e-07 | 16 | 64 | 4 | CID000004598 | |
| Drug | fendiline | 1.01e-07 | 16 | 64 | 4 | CID000003336 | |
| Drug | Mastoparan X | 1.31e-07 | 17 | 64 | 4 | CID005488554 | |
| Drug | desmethoxyverapamil | 1.31e-07 | 17 | 64 | 4 | CID000065832 | |
| Drug | Org 9935 | 1.31e-07 | 17 | 64 | 4 | CID000131100 | |
| Drug | ICI D7114 | 1.31e-07 | 17 | 64 | 4 | CID000121877 | |
| Drug | ethylene glycol tetraacetic acid | 1.49e-07 | 44 | 64 | 5 | CID000006207 | |
| Drug | chlorpromazine sulfoxide | 1.69e-07 | 18 | 64 | 4 | CID000070413 | |
| Drug | 8-azido cyclic AMP | 1.69e-07 | 18 | 64 | 4 | CID000115296 | |
| Drug | AC1L19BP | 1.69e-07 | 18 | 64 | 4 | CID000000477 | |
| Drug | H-9 dihydrochloride | 2.01e-07 | 90 | 64 | 6 | CID000003544 | |
| Drug | LaCl3 | 2.10e-07 | 47 | 64 | 5 | CID000064735 | |
| Drug | jujubogenin | 2.11e-07 | 5 | 64 | 3 | CID005318721 | |
| Drug | Y-acid | 2.11e-07 | 5 | 64 | 3 | CID000007022 | |
| Drug | AC1NS8P3 | 2.11e-07 | 5 | 64 | 3 | CID005356151 | |
| Drug | Ant-ATP | 2.11e-07 | 5 | 64 | 3 | CID000134953 | |
| Drug | MABI | 2.13e-07 | 19 | 64 | 4 | CID000188268 | |
| Drug | 4pal | 2.66e-07 | 20 | 64 | 4 | CID005748175 | |
| Drug | DEPMPO | 2.66e-07 | 20 | 64 | 4 | CID000119606 | |
| Drug | Frenolon | 3.28e-07 | 21 | 64 | 4 | CID000009800 | |
| Drug | KS-619-1 | 3.28e-07 | 21 | 64 | 4 | CID000128369 | |
| Drug | decanoylcarnitine | 3.28e-07 | 21 | 64 | 4 | CID000150921 | |
| Drug | P12-14 | 3.28e-07 | 21 | 64 | 4 | CID000626783 | |
| Drug | K-259-2 | 3.28e-07 | 21 | 64 | 4 | CID006438946 | |
| Drug | 2brh | 3.28e-07 | 21 | 64 | 4 | CID000848641 | |
| Drug | Camphor | 3.51e-07 | 52 | 64 | 5 | CID000002537 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 3.92e-09 | 10 | 63 | 4 | C1631597 | |
| Disease | laminin subunit gamma-2 measurement | 4.49e-06 | 2 | 63 | 2 | EFO_0801756 | |
| Disease | Romano-Ward Syndrome | 5.09e-06 | 16 | 63 | 3 | C0035828 | |
| Disease | Phencyclidine-Related Disorders | 9.36e-05 | 7 | 63 | 2 | C0236742 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 9.36e-05 | 7 | 63 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | Phencyclidine Abuse | 9.36e-05 | 7 | 63 | 2 | C0031391 | |
| Disease | Cannabis Abuse | 2.00e-04 | 10 | 63 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 2.00e-04 | 10 | 63 | 2 | C0236735 | |
| Disease | Hashish Abuse | 2.00e-04 | 10 | 63 | 2 | C0018614 | |
| Disease | Cannabis Dependence | 5.98e-04 | 17 | 63 | 2 | C0006870 | |
| Disease | Hypertriglyceridemia | 7.49e-04 | 19 | 63 | 2 | EFO_0004211 | |
| Disease | Brugada Syndrome (disorder) | 1.20e-03 | 24 | 63 | 2 | C1142166 | |
| Disease | corpus callosum volume measurement | 1.29e-03 | 100 | 63 | 3 | EFO_0010299 | |
| Disease | systemic scleroderma, systemic lupus erythematosus | 1.41e-03 | 26 | 63 | 2 | EFO_0000717, MONDO_0007915 | |
| Disease | Marijuana Abuse | 1.88e-03 | 30 | 63 | 2 | C0024809 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSEEEIREAFRVFDK | 81 | P0DP25 | |
| DEEDRQQEFRREFEK | 436 | Q9Y4B4 | |
| SRFFEEKHRLEQEAE | 186 | Q8ND07 | |
| DSEEEIREAFRVFDK | 81 | P0DP24 | |
| EIEELREAFREFDKD | 226 | Q9NZU7 | |
| EEEEDRFKEEFQRLQ | 911 | P78312 | |
| EQAVARKEEAREEFL | 311 | Q9Y2G4 | |
| EAVFEAREQKERFEA | 56 | Q9UKA8 | |
| FREDDFRRVVDFIDE | 436 | P34897 | |
| AFLRENFEAVAREDE | 156 | Q0D2K2 | |
| SEIREDDEAFEARVK | 3046 | Q01484 | |
| RRVDIDEFDENKFVD | 11 | Q9BPX5 | |
| EFFDAVEAALDRQDK | 321 | Q9Y5P4 | |
| EERLFELVSDFDRKE | 236 | Q8N7Z5 | |
| DEEALARAQEDFFQK | 306 | O95278 | |
| KEENDDFASFRVDRI | 166 | P04196 | |
| IVEAASDDERRKAFA | 256 | A8MVJ9 | |
| RRQAEEKFIEFEDAL | 101 | Q9UPT6 | |
| RFRTDEADDVKFAVR | 136 | O60524 | |
| FIDAAQEARNKFEEA | 366 | P14314 | |
| EELREAFLEFDKDRD | 31 | Q9NP86 | |
| EDEETLARRFRKDFE | 516 | Q69YN2 | |
| ARRVDEVFEDAFEQE | 696 | Q63HM2 | |
| FRKFSEQDDSVERDI | 536 | Q8WWI1 | |
| RRDELEFEKEVKNSF | 256 | Q99689 | |
| TKFAEEEDVRRSFEN | 241 | P59047 | |
| EKKEEFQDESEFRRQ | 251 | Q96P66 | |
| DDDKRRELVNFFKEF | 326 | Q5MIZ7 | |
| EFEELRSCREFEDQK | 66 | Q8TCB7 | |
| ILEDQDVDKRDFFDN | 201 | P30532 | |
| EEIREAFKVFDRDGN | 36 | Q86V35 | |
| ERTAFIDFVEKDREP | 86 | Q9BQW3 | |
| DDDVFFRELEAERFR | 791 | Q96GE4 | |
| VTDQAFEDRLKEAER | 1066 | P11047 | |
| REFDLQVDNRKAEAE | 956 | Q13753 | |
| DNEEEIREAFRVFDK | 81 | P27482 | |
| DSEEEIREAFRVFDK | 81 | P0DP23 | |
| DRCVSFQARFAEKEE | 126 | Q9UBN7 | |
| ETEEEQRFRALFEQV | 516 | O14815 | |
| KEFFEHIERERASDV | 811 | Q8IVF4 | |
| EELQVAFQEFDRDRD | 81 | Q9NPB3 | |
| KFRENVEDVFREAAK | 176 | Q9HBH0 | |
| FERAEEEARKEETEA | 811 | Q24JP5 | |
| EEDKNRAIEEAFARA | 336 | Q9BVG8 | |
| EFEERAKAIIVEFAQ | 786 | O60841 | |
| EEAERNIFKDVFNRI | 266 | Q8NHV1 | |
| DKDDQRTFRDVVRFE | 691 | Q5UE93 | |
| DAFSNEEAVRFIKER | 306 | Q5SGD2 | |
| DQDRFEKNFRVDVVH | 41 | O15160 | |
| IFDQCVADREEAFKE | 146 | Q9UEE5 | |
| DNRVLSEVDFEERFA | 1346 | Q96RK0 | |
| VKIFEEDFQRERSDR | 466 | Q15025 | |
| VQDDEVAETVFRDRK | 371 | Q9P2K2 | |
| DEEFRENNIEIVTRF | 81 | Q12768 | |
| DINKEEEFVEEFNRL | 16 | P98170 | |
| KEEEQERQELFASRF | 1516 | Q96T58 | |
| REKVNKAAVFEEEDF | 161 | Q5VZE5 | |
| RQQEEEKAEARAFEE | 91 | O43818 | |
| RDFVEEDNQRFEKEL | 686 | Q9UHP3 | |
| FAKEFVDAREREKNF | 171 | Q9H1J7 | |
| AEEDAQRFRKQAEEI | 2536 | Q15149 | |
| RDIRREIDDFFKADD | 51 | Q7Z3V4 | |
| FDDPEVDARVRKVDA | 251 | Q96NB3 | |
| AFREEAIKFSEEQRF | 641 | P13010 | |
| EDEREFDKENEVFRD | 336 | Q86VM9 |